Development and Evaluation of Novel Anti-HER2 Theranostics Against HER2-Positive Breast Cancer
Date
2024-09-20
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
ORCID
0000-0002-4574-8720
Type
Thesis
Degree Level
Doctoral
This item is under an embargo.
Access to the abstract and all associated documents will not be permitted until 2025-09-20.
Description
Keywords
HER2-positive breast cancer, Theranostics, Actinium-225, Copper-67, Zirconium-89, Trastuzumab-Resistance, Dosimetry, Toxicology, Radioimmunotherapy, Antibody-drug conjugates, PEGylation
Citation
Degree
Doctor of Philosophy (Ph.D.)
Department
Medicine
Program
Health Sciences